Liu, Y., Dong, C., He, X., Shu, Y., Wu, P., & Zou, J. (2022). Post-Marketing Safety of Vemurafenib: A Real-World Pharmacovigilance Study of the FDA Adverse Event Reporting System. Journal of Pharmacy & Pharmaceutical Sciences, 25, 377–390. https://doi.org/10.18433/jpps33020